Transpek Inds
Fundamental Score
Transpek Inds Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of TRANSPEK across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Operating Margins (16.16%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Attractive Valuation (P/E: 12.55 vs Industry: 20.98)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (32.36%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Conservative Debt Levels (D/E: 0.05)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (8.05x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Strong Cash Generation (₹271.46 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (57.47%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
5 factors identified
Below-Average Return on Equity (7.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Limited Growth History (2.81% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.
Weak Earnings Growth (-5.59% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Stagnant Profit Growth (-5.59% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.
Limited Institutional Interest (FII+DII: 1.67%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
Financial Statements
Comprehensive financial data for Transpek Inds
About TRANSPEK
Company Details
Latest News
TRANSPEK Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Transpek Inds (TRANSPEK)?
As of 02 Jan 2026, 04:06 pm IST, Transpek Inds (TRANSPEK) is currently trading at ₹1305.55. The stock has a market capitalization of ₹729.22 (Cr).
Is TRANSPEK share price Overvalued or Undervalued?
TRANSPEK is currently trading at a P/E ratio of 12.55x, compared to the industry average of 20.98x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Transpek Inds share price?
Key factors influencing TRANSPEK's price include its quarterly earnings growth (Sales Growth: -1.49%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Transpek Inds a good stock for long-term investment?
Transpek Inds shows a 5-year Profit Growth of -5.59% and an ROE of 7.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.05 before investing.
How does Transpek Inds compare with its industry peers?
Transpek Inds competes with major peers in the Commodity Chemicals. Investors should compare TRANSPEK's P/E of 12.55x and ROE of 7.75% against the industry averages to determine its competitive standing.
What is the P/E ratio of TRANSPEK and what does it mean?
TRANSPEK has a P/E ratio of 12.55x compared to the industry average of 20.98x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹13 for every ₹1 of annual earnings.
How is TRANSPEK performing according to Bull Run's analysis?
TRANSPEK has a Bull Run fundamental score of 41.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does TRANSPEK belong to?
TRANSPEK operates in the Commodity Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Transpek Inds.
What is Return on Equity (ROE) and why is it important for TRANSPEK?
TRANSPEK has an ROE of 7.75%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Transpek Inds generates profits from shareholders' equity.
How is TRANSPEK's debt-to-equity ratio and what does it indicate?
TRANSPEK has a debt-to-equity ratio of 0.05, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is TRANSPEK's dividend yield and is it a good dividend stock?
TRANSPEK offers a dividend yield of 1.53%, which means you receive ₹1.53 annual dividend for every ₹100 invested.
How has TRANSPEK grown over the past 5 years?
TRANSPEK has achieved 5-year growth rates of: Sales Growth 2.81%, Profit Growth -5.59%, and EPS Growth -5.59%.
What is the promoter holding in TRANSPEK and why does it matter?
Promoters hold 57.47% of TRANSPEK shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is TRANSPEK's market capitalization category?
TRANSPEK has a market capitalization of ₹729 crores, placing it in the Small-cap category.
How volatile is TRANSPEK stock?
TRANSPEK has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for TRANSPEK?
TRANSPEK has a 52-week high of ₹N/A and low of ₹N/A.
What is TRANSPEK's operating profit margin trend?
TRANSPEK has a 5-year average Operating Profit Margin (OPM) of 16.16%, indicating the company's operational efficiency.
How is TRANSPEK's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -1.49% and YoY Profit Growth of 32.36%.
What is the institutional holding pattern in TRANSPEK?
TRANSPEK has FII holding of 0.03% and DII holding of 1.64%. Significant institutional holding often suggests professional confidence in the stock.